Advanced search×

[Antipsychotics in clinical practice. The refractory schizophrenic patients treatment].

Joanna J Meder, Magdalena M Tyszkowska, Marek M Jarema, Aleksander A Araszkiewicz, and Tomasz T Szafrański

Psychiatr Pol 42(6):859-73 (2008) PMID 19441664

The aim of this paper is to present and to discuss the results of an investigation conducted among Polish psychiatrists in 2007, especially its part relating to the practice of therapeutic patterns in refractory schizophrenia.

Version: za2963e q8za1 q8zbf q8zc0 q8zd4 q8zef q8zff q8zgc

Similar articles you may find interesting…

  1. Risperidone and lamotrigine: no evidence of a drug interaction.
    Ingrid Castberg and Olav Spigset

    J Clin Psychiatry 67(7):1159 (2006) PMID 16889467

  2. Cabergoline treatment of risperidone-induced hyperprolactinemia: a pilot study.
    Roberto Cavallaro, Federica Cocchi, ... Enrico Smeraldi

    J Clin Psychiatry 65(2):187-90 (2004) PMID 15003071

    Results suggest that low-dose cabergoline treatment of risperidone-induced hyperprolactinemia may be safe and clinically effective in a relevant number of patients....
  3. [Risperidone use in child and adolescent psychiatric patients].
    Claire C Chevreuil, Jean-Michel JM Reymann, ... Danièle D Bentué-Ferrer

    Therapie 63(5):359-75 (2008) PMID 19154706

    We have done a review of the literature on the effectiveness and the cautions for prescription of risperidone, a second generation antipsychotic drug. Risperidone has proved helpful in treating children and adolescents with autism spectrum, conduct and bipolar disorders, Tourette's syndrome, and sch...